Muscle injury in organophosphorous poisoning and its role in the development of intermediate syndrome

NeuroToxicology

Volumn 24, Issue 1, 2003, Pages 43-53

  John, M ^a   Oommen, A ^a   Zachariah, A ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Acetylcholinesterase; Creatine kinase; Intermediate syndrome; Lactic dehydrogenase; Muscle injury; Organophosphate poisoning

Indexed keywords

ACETYLCHOLINESTERASE; CREATINE KINASE; CREATINE KINASE MM; LACTATE DEHYDROGENASE; MUSCLE ENZYME; ORGANOPHOSPHATE INSECTICIDE;

ACUTE TOXICITY; ADULT; ARTICLE; CHOLINERGIC ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE DURATION; DISEASE SEVERITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; FASCICULATION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INTERMEDIATE SYNDROME; INTOXICATION; LACTATE DEHYDROGENASE BLOOD LEVEL; MUSCLE INJURY; MUSCLE WEAKNESS; NEUROTOXICITY; PARALYSIS; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; ADULT; HUMANS; MUSCLE WEAKNESS; MUSCLE, SKELETAL; ORGANOPHOSPHORUS COMPOUNDS; PARALYSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC;

EID: 0037235909     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-813X(02)00111-0     Document Type: Article

References (27)

1. Avasthi G, Singh G. Serial neuro-electrophysiological studies in acute organophosphate poisoning; correlation with clinical findings, serum cholinesterase levels and atropine dosages. J Assoc Physicians India 2000;48:794-9.
2. De Bleecker J, VanDen Neuker K, Colardyn F. Intermediate syndrome in organophosphorous piosoning: a prospective study. Crit Care Med 1993;23:1706-11.
3. De Bleecker J. The intermediate syndrome in organophosphate poisoning: an overview of experimental and clinical observations. Clin Toxicol 1995;33:683-6.
4. De Bleecker JL, Meire VI, Pappens S. Quinidine prevents paraoxon-induced necrotizing myopathy in rats. Neurotoxicology 1998; 19:833-8.
5. DGKC. J Clin Chem Clin Biochem 1977;20:235.
6. De Reuck J, Willems J. Acute parathion poisoning: myopathic changes in the diaphragm. J Neurol 1975;208(4):309-13.
7. Eddleston M. Patterns and problems of deliberate self-poisoning in the developing world. Q J Med 2000;93:715-31.
8. Ellman GL, Courtney KD, Andres Jr, V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
9. Golomb BA. Does pyridostigmine bromide produce neuromuscular junctional changes? A review of the scientific literature as it pertains to Gulf War Illness, vol. 2. RAND 1999 [chapter 12] (from http://www.gulflink.osd.mil/library/randrep/pb_paper/mr1018.2 chap12.html).
10. He F. Occupational neurotoxic diseases in developing countries. In: Costa LG, Manzo L, editors. Occupational neurotoxicology. Boca Raton, USA: CRC Press; 1998. p. 259-69.
11. IFCC. Method for lactic dehydrogenase. Eur J Clin Chem Clin Biochem 1994;32:639.
12. Jeyaratnam J. Acute pesticide poisoning: a major health problem. World Health Stat Q 1990;43:139-44.
13. Jeyarasingam G, Yeluashvili M, Quik M. Nitric oxide is involved in acetylcholinesterase inhibitor-induced myopathy in rats. J Pharmacol Exp Therapeut 2000;295:314-20.
14. Karalliedde L. Organophosphorus poisoning and anaesthesia. Anaesthesia 1999;54:1073-88.
15. Khan S, Hemalatha R, Jeyaseelan L, Oommen A, Zachariah A. Neuroparalysis and oxime efficacy in organophosphate poisoning: a study of butyrylcholinesterase. Hum Exp Toxicol 2001; 20:169-74.
16. Leonard JP, Salpeter MM. Agonist induced myopathy at the neuromuscular junction is mediated by calcium. J Cell Biol 1979;82:811-9.
17. Lowry HO, Rosenbrough NH, Farr Al, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
18. Marchesi VT. Isolation of spectrin from erythrocyte membranes. Methods Enzymol 1974;32(Part B):275-7.
19. Namba T, Nolte CT, Jackrel J, et al. Poisoning due to organophosphorous compounds. Am J Med 1971;50:475-92.
20. Peter JV, Cherian AM. Organic insecticides. Anaesth Intensive Care 2000;28:11-21.
21. Quistad GB, Sparks S, Casida JE. Fatty acid amide hydrolase inhibition by neurotoxic organophosphorous pesticides. Toxicol Appl Pharmacol 2001;173:48-55.
22. Ralph WK. Toxic myopathies. Neurol Clin 1988;6:593-619.
23. Samuel J, Thomas K, Jeyaseelan L, Peter JV, Cherian AM. Incidence of intermediate syndrome in organophosphorus poisoning. J Assoc Physicians India 1995;43:321-3.
24. Senanayake N, Karalliedde L. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N Engl J Med 1987;316:761-3.
25. Siwach SB, Gupta A. The profile of acute poisonings in the Haryana Rohtak area. J Assoc Physicians India 1995;3:756-9.
26. Wadia RS, Sadagopan C, Amin RP, Sardesai HV. Neurological manifestations of organophosphorous insecticide poisoning. J Neurol Neurosurg Psychiatr 1974;37:841-7.
27. Yang ZP, Dettbarn WD. Lipid peroxidation and changes in cytochrome c oxidase and xanthine oxidase activity in organophosphorous anticholinesterase induced myopathy. J Physiol 1998; 92:157-61.